KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EBIT (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.19%
Dec 31, 2025 138.66%
Sep 30, 2025 -61.10%
Jun 30, 2025 31.10%
Mar 31, 2025 350.54%
Dec 31, 2024 -138.89%
Sep 30, 2024 -4.18%
Jun 30, 2024 42.89%
Mar 31, 2024 -12.43%
Dec 31, 2023 40.07%
Sep 30, 2023 -49.46%
Jun 30, 2023 63.04%
Mar 31, 2023 -49.69%
Dec 31, 2022 19.53%
Sep 30, 2022 39.70%
Jun 30, 2022 -30.15%
Mar 31, 2022 -7.04%
Dec 31, 2021 17.84%
Sep 30, 2021 -3.04%
Jun 30, 2021 8.24%
Mar 31, 2021 9.33%
Dec 31, 2020 15.30%
Sep 30, 2020 332.85%
Jun 30, 2020 -79.13%
Mar 31, 2020 -8.92%
Dec 31, 2019 51.17%
Sep 30, 2019 -23.03%
Jun 30, 2019 12.96%
Mar 31, 2019 223.31%
Dec 31, 2018 -177.27%
Sep 30, 2018 14.37%
Jun 30, 2018 -4.86%
Mar 31, 2018 62.91%
Dec 31, 2017 -33.85%
Sep 30, 2017 1.20%
Jun 30, 2017 10.59%
Mar 31, 2017 4.02%
Dec 31, 2016 -1.99%
Sep 30, 2016 2,723.33%
Jun 30, 2016 -103.95%
Mar 31, 2016 7.81%
Dec 31, 2015 12.10%
Sep 30, 2015 459.35%
Jun 30, 2015 -80.02%
Mar 31, 2015 506.51%
Dec 31, 2014 -143.23%
Sep 30, 2014 -36.63%
Jun 30, 2014 12.14%
Mar 31, 2014 -11.99%
Dec 31, 2013 11.96%
Sep 30, 2013 -5.64%
Jun 30, 2013 11.34%
Mar 31, 2013 -28.34%
Dec 31, 2012 14.10%
Sep 30, 2012 12.24%
Jun 30, 2012 45.40%